Aleksei Skripkin

Aleksei Skripkin serves as the Clinical Safety and Pharmacovigilance Director and Head of the Drug Safety Department at R-Pharm since September 2020, where responsibilities encompass a comprehensive range of clinical safety and pharmacovigilance functions. Prior to this role, Aleksei was the Head of Pharmacovigilance Service at Veropharm from May 2017 to August 2020, overseeing pharmacovigilance obligations for a 130-medicine portfolio, and held positions at BIOCAD from February 2010 to February 2017, including Head of the Drug Safety Department and Medical Advisor in neurology. Educational qualifications include a Medical Doctor degree in Pediatrics from Rostov State Medical University, a residency in Neurology, and postgraduate studies in Neurology at Moscow State Medical Academy.